Drug intelligence / Profile preview

Qiju Dihuang Tablets

Development stage
Unknown
Lead developer
Hebei Wanbang Fu Lin Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Qiju Dihuang Tablets (杞菊地黄片) is a traditional Chinese medicine (TCM) formulation manufactured by Hebei Wanbang Fu Lin Pharmaceutical. It is an oral tablet based on the classic Qiju Dihuang formula, which is an enhancement of the Liuwei Dihuang base with the addition of Lycium fruit (Gouqizi) and Chrysanthemum flower (Juhua). The formulation is traditionally indicated as a liver and kidney tonic, specifically for treating Yin deficiency of the liver and kidney. It is used to alleviate symptoms such as dizziness, tinnitus, photophobia, blurred vision, and tearing when exposed to wind. As a TCM product, it operates through a multi-component and multi-target mechanism involving various phytochemicals from its constituent herbs, rather than a single defined biological target.

Brand names
杞菊地黄片
Other names
Qiju Dihuang PianQiju Dihuang-Hebei Wanbang Fu Lin Pharmaceutical
02

Targets

M1 (Muscarinic acetylcholine receptor M1)ESR1 (ERα)

Beyond the preview

Go deeper on Qiju Dihuang Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qiju Dihuang Tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call